Rfg Advisory, LLC Invitae Corp Transaction History

Rfg Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$24.31 - $33.6 $517,681 - $715,512	-21,295 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$26.09 - $40.4 $55,441 - $85,850	2,125 Added 11.09%	21,295 $718,000
Q1 2021 Apr 19, 2021	BUY	$33.06 - $56.93 $62,814 - $108,167	1,900 Added 11.0%	19,170 $732,000
Q4 2020 Feb 02, 2021	SELL	$39.09 - $57.4 $185,677 - $272,650	-4,750 Reduced 21.57%	17,270 $883,000
Q3 2020 Oct 13, 2020	BUY	$28.43 - $44.67 $228,861 - $359,593	8,050 Added 57.62%	22,020 $955,000
Q2 2020 Aug 03, 2020	BUY	$11.71 - $30.29 $163,588 - $423,151	13,970 New	13,970 $423,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rfg Advisory, LLC with notifications on news.